Thomas Frank E (CIK 0001242616)

Latest company ownership

Shares held
19,000
Last filed at
May 31, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2024Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 14, 2024 Feb 15, 2024 Larimar Therapeutics, Inc. Director Buy 91.3 +2,000 100.00% $22K